Interim recommendations for use of recombinant COVID-19 vaccine updated to reflect latest evidence

The interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to reflect latest evidence.

For further information, see below:

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19

Source:

The World Health Organization

Posted in: Disease/Infection News | Healthcare News

Tags: Vaccine

Comments (0)

Source: Read Full Article